Cargando…

Tat-functionalized Ag-Fe(3)O(4) nano-composites as tissue-penetrating vehicles for tumor magnetic targeting and drug delivery

In this paper, we prepared a dual functional system based on dextrin-coated silver nanoparticles which were further attached with iron oxide nanoparticles and cell penetrating peptide (Tat), producing Tat-modified Ag-Fe(3)O(4) nanocomposites (Tat-FeAgNPs). To load drugs, an –SH containing linker, 3-...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ergang, Zhang, Meng, Cui, Hui, Gong, Junbo, Huang, Yongzhuo, Wang, Jianxin, Cui, Yanna, Dong, Weibing, Sun, Lu, He, Huining, Yang, Victor C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251815/
https://www.ncbi.nlm.nih.gov/pubmed/30505664
http://dx.doi.org/10.1016/j.apsb.2018.07.012
_version_ 1783373149497196544
author Liu, Ergang
Zhang, Meng
Cui, Hui
Gong, Junbo
Huang, Yongzhuo
Wang, Jianxin
Cui, Yanna
Dong, Weibing
Sun, Lu
He, Huining
Yang, Victor C.
author_facet Liu, Ergang
Zhang, Meng
Cui, Hui
Gong, Junbo
Huang, Yongzhuo
Wang, Jianxin
Cui, Yanna
Dong, Weibing
Sun, Lu
He, Huining
Yang, Victor C.
author_sort Liu, Ergang
collection PubMed
description In this paper, we prepared a dual functional system based on dextrin-coated silver nanoparticles which were further attached with iron oxide nanoparticles and cell penetrating peptide (Tat), producing Tat-modified Ag-Fe(3)O(4) nanocomposites (Tat-FeAgNPs). To load drugs, an –SH containing linker, 3-mercaptopropanohydrazide, was designed and synthesized. It enabled the silver carriers to load and release doxorubicin (Dox) in a pH-sensitive pattern. The delivery efficiency of this system was assessed in vitro using MCF-7 cells, and in vivo using null BalB/c mice bearing MCF-7 xenograft tumors. Our results demonstrated that both Tat and externally applied magnetic field could promote cellular uptake and consequently the cytotoxicity of doxorubicin-loaded nanoparticles, with the IC(50) of Tat-FeAgNP-Dox to be 0.63 µmol/L. The in vivo delivery efficiency of Tat-FeAgNP carrying Cy5 to the mouse tumor was analyzed using the in vivo optical imaging tests, in which Tat-FeAgNP-Cy5 yielded the most efficient accumulation in the tumor (6.7±2.4% ID of Tat-FeAgNPs). Anti-tumor assessment also demonstrated that Tat-FeAgNP-Dox displayed the most significant tumor-inhibiting effects and reduced the specific growth rate of tumor by 29.6% (P = 0.009), which could be attributed to its superior performance in tumor drug delivery in comparison with the control nanovehicles.
format Online
Article
Text
id pubmed-6251815
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-62518152018-11-30 Tat-functionalized Ag-Fe(3)O(4) nano-composites as tissue-penetrating vehicles for tumor magnetic targeting and drug delivery Liu, Ergang Zhang, Meng Cui, Hui Gong, Junbo Huang, Yongzhuo Wang, Jianxin Cui, Yanna Dong, Weibing Sun, Lu He, Huining Yang, Victor C. Acta Pharm Sin B Original article In this paper, we prepared a dual functional system based on dextrin-coated silver nanoparticles which were further attached with iron oxide nanoparticles and cell penetrating peptide (Tat), producing Tat-modified Ag-Fe(3)O(4) nanocomposites (Tat-FeAgNPs). To load drugs, an –SH containing linker, 3-mercaptopropanohydrazide, was designed and synthesized. It enabled the silver carriers to load and release doxorubicin (Dox) in a pH-sensitive pattern. The delivery efficiency of this system was assessed in vitro using MCF-7 cells, and in vivo using null BalB/c mice bearing MCF-7 xenograft tumors. Our results demonstrated that both Tat and externally applied magnetic field could promote cellular uptake and consequently the cytotoxicity of doxorubicin-loaded nanoparticles, with the IC(50) of Tat-FeAgNP-Dox to be 0.63 µmol/L. The in vivo delivery efficiency of Tat-FeAgNP carrying Cy5 to the mouse tumor was analyzed using the in vivo optical imaging tests, in which Tat-FeAgNP-Cy5 yielded the most efficient accumulation in the tumor (6.7±2.4% ID of Tat-FeAgNPs). Anti-tumor assessment also demonstrated that Tat-FeAgNP-Dox displayed the most significant tumor-inhibiting effects and reduced the specific growth rate of tumor by 29.6% (P = 0.009), which could be attributed to its superior performance in tumor drug delivery in comparison with the control nanovehicles. Elsevier 2018-10 2018-08-06 /pmc/articles/PMC6251815/ /pubmed/30505664 http://dx.doi.org/10.1016/j.apsb.2018.07.012 Text en © 2018 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original article
Liu, Ergang
Zhang, Meng
Cui, Hui
Gong, Junbo
Huang, Yongzhuo
Wang, Jianxin
Cui, Yanna
Dong, Weibing
Sun, Lu
He, Huining
Yang, Victor C.
Tat-functionalized Ag-Fe(3)O(4) nano-composites as tissue-penetrating vehicles for tumor magnetic targeting and drug delivery
title Tat-functionalized Ag-Fe(3)O(4) nano-composites as tissue-penetrating vehicles for tumor magnetic targeting and drug delivery
title_full Tat-functionalized Ag-Fe(3)O(4) nano-composites as tissue-penetrating vehicles for tumor magnetic targeting and drug delivery
title_fullStr Tat-functionalized Ag-Fe(3)O(4) nano-composites as tissue-penetrating vehicles for tumor magnetic targeting and drug delivery
title_full_unstemmed Tat-functionalized Ag-Fe(3)O(4) nano-composites as tissue-penetrating vehicles for tumor magnetic targeting and drug delivery
title_short Tat-functionalized Ag-Fe(3)O(4) nano-composites as tissue-penetrating vehicles for tumor magnetic targeting and drug delivery
title_sort tat-functionalized ag-fe(3)o(4) nano-composites as tissue-penetrating vehicles for tumor magnetic targeting and drug delivery
topic Original article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251815/
https://www.ncbi.nlm.nih.gov/pubmed/30505664
http://dx.doi.org/10.1016/j.apsb.2018.07.012
work_keys_str_mv AT liuergang tatfunctionalizedagfe3o4nanocompositesastissuepenetratingvehiclesfortumormagnetictargetinganddrugdelivery
AT zhangmeng tatfunctionalizedagfe3o4nanocompositesastissuepenetratingvehiclesfortumormagnetictargetinganddrugdelivery
AT cuihui tatfunctionalizedagfe3o4nanocompositesastissuepenetratingvehiclesfortumormagnetictargetinganddrugdelivery
AT gongjunbo tatfunctionalizedagfe3o4nanocompositesastissuepenetratingvehiclesfortumormagnetictargetinganddrugdelivery
AT huangyongzhuo tatfunctionalizedagfe3o4nanocompositesastissuepenetratingvehiclesfortumormagnetictargetinganddrugdelivery
AT wangjianxin tatfunctionalizedagfe3o4nanocompositesastissuepenetratingvehiclesfortumormagnetictargetinganddrugdelivery
AT cuiyanna tatfunctionalizedagfe3o4nanocompositesastissuepenetratingvehiclesfortumormagnetictargetinganddrugdelivery
AT dongweibing tatfunctionalizedagfe3o4nanocompositesastissuepenetratingvehiclesfortumormagnetictargetinganddrugdelivery
AT sunlu tatfunctionalizedagfe3o4nanocompositesastissuepenetratingvehiclesfortumormagnetictargetinganddrugdelivery
AT hehuining tatfunctionalizedagfe3o4nanocompositesastissuepenetratingvehiclesfortumormagnetictargetinganddrugdelivery
AT yangvictorc tatfunctionalizedagfe3o4nanocompositesastissuepenetratingvehiclesfortumormagnetictargetinganddrugdelivery